Skip to main content
Top

ESMO 2023: A new option for thyroid cancer

Host:
Dr. Shreeya Nanda

Senior Clinical Content Manager, Springer Medicine

Dr. Laura Locati comments on the LIBRETTO-531 study of selpercatinib in previously untreated RET-mutant medullary thyroid carcinoma, which has provided a new treatment option for this patient population.

Speaker

  • Dr. Laura Locati
    University of Pavia, Italy

Keynote webinar | Spotlight on progress in colorectal cancer

CRC remains a major global health burden, but advances in screening, treatment, and lifestyle-based prevention continue to reshape clinical practice. Gain insights into how the latest research can be leveraged to optimize patient care across the CRC continuum.

Prof. Antoni Castells
Prof. Harpreet Wasan
Prof. Edward Giovannucci
Watch now
Image Credits
Laura Locati/© Laura Locati, Colon cancer illustration/© (M) KATERYNA KON / SCIENCE PHOTO LIBRARY / Getty Images